News

Article

Bausch + Lomb, Glaucoma Research Foundation partner for second annual Faces of Glaucoma campaign

Key Takeaways

  • Faces of Glaucoma campaign highlights patient stories and promotes glaucoma awareness during Glaucoma Awareness Month.
  • Bausch + Lomb supports a fundraising initiative, matching up to $20,000 for glaucoma research.
SHOW MORE

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management.

(Image Credit: AdobeStock/Timon)

(Image Credit: AdobeStock/Timon)

Bausch + Lomb and Glaucoma Research Foundation have partnered to launch the second annual Faces of Glaucoma campaign. The campaign, aimed at highlighting diverse patient stories and raising awareness of glaucoma will take place throughout Glaucoma Awareness Month in January.

Throughout the month, Bausch + Lomb and GRF will spotlight educational resources and share stories of individuals and families living with glaucoma to raise awareness and encourage proactive eye health management. In addition, B+L will support a fundraising campaign, matching up to $20,000, which will support GRF research on a potential cure for glaucoma.

The search for a cure for glaucoma is led by Catalyst for a Cure, Glaucoma Research Foundation’s flagship research program. According to the organization, the Catalyst for a Cure initiative brings together neuroscientists and glaucoma specialists to study glaucoma, find better treatments, and accelerate progress toward vision restoration and a cure.

Materials from the campaign are available online and include information on lifestyle tips for glaucoma patients as well as what can be done to prevent glaucoma.

Andrew Stewart, president of global pharmaceuticals and international consumer, Bausch + Lomb discussed the initiative in a press release from the company.

“It’s estimated that half of people with glaucoma don’t know that they have it, demonstrating a need for continuing education and awareness efforts,” said Stewart. “In collaboration with Glaucoma Research Foundation, we aim to encourage people to take an active role in understanding and managing their risk, starting with seeing an eye doctor.”

Early detection being key, the organizations state that glaucoma checkups should be conducted:

  • before age 40, every two to four years
  • from age 40 to age 54, every one to three years
  • from age 55 to 64, every one to two years
  • after age 65, every six to 12 months
References:
  1. Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge. Press Release. Published January 7, 2025. Accessed January 7, 2025.https://www.businesswire.com/news/home/20250107193963/en/Bausch-Lomb-and-Glaucoma-Research-Foundation-Launch-Second-Annual-%E2%80%9CFaces-of-Glaucoma%E2%80%9D-Campaign-and-Fundraising-Challenge
Related Videos
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
(Image credit: Ophthalmology Times) AGS 2025: Two-year data of bio-interventional cyclodialysis with scleral allograft with Leon W. Herndon Jr, MD
© 2025 MJH Life Sciences

All rights reserved.